Dr. Gammon received his B.S. degree in Biological Sciences at the University of Windsor (Windsor, Canada) and went on to obtain his Ph.D. in Virology at the University of Alberta (Edmonton, Canada) in the laboratory of Dr. David Evans. While at the University of Alberta, Dr. Gammon’s research helped to elucidate the genetic and biochemical nature of poxvirus resistance to clinically-important acyclic nucleoside phosphonate drugs. In addition, he identified an unusual role for poxvirus DNA polymerase proofreading activity in catalyzing genetic recombination in virus-infected cells. His work also showed that poxviruses usurp host nucleotide biosynthetic machinery by forming novel “chimeric” ribonucleotide reductase enzymes that contain both viral and host proteins. This discovery led to Drs. Gammon and Evans obtaining a U.S. patent for the use of ribonucleotide reductase-deficient poxviruses in oncolytic virotherapy.

Upon completion of his graduate research, Dr. Gammon pursued post-doctoral training in the laboratory of Nobel Laureate, Dr. Craig Mello, at the University of Massachusetts Medical School. In the Mello laboratory, he developed novel RNA virus-Lepidopteran (moth and butterfly) host systems to uncover both the immunity mechanisms used by eukaryotic organisms to restrict virus replication as well as the strategies viruses employ to counter such restrictions. These model systems arose from the observation that certain arboviruses undergo an abortive infection in Lepidopteran cells yet can replicate in these cells when host immunity is compromised during co-infection with other viruses, such as poxviruses. Using these model systems, his work has uncovered multiple conserved eukaryotic host factors that restrict arbovirus replication. These studies also identified a new family of highly conserved, microtubule-stabilizing virulence factors encoded by poxviruses that promote virus replication in Lepidopteran and vertebrate hosts. The Gammon laboratory uses a wide variety of cell culture-, virology-, molecular/cell biology, immunology, and biochemistry-related techniques to explore virus-host interplay. Using this multifaceted approach, along with newly-developed virus-host systems, Dr. Gammon’s team seeks to define the viral and host factors that ultimately determine virus host range and disease outcomes.


University of Windsor (2004), Biological Sciences
Graduate School
University of Alberta (2010), Virology

Research Interest

  • Host-pathogen interactions
  • Invertebrate host model systems
  • RNA/DNA virus replication, immune evasion, and pathogenesis
  • Viral manipulation of host cytoskeletal networks


Featured Publications LegendFeatured Publications

Abortive Infection of Animal Cells: What Goes Wrong
Embry, A., and Gammon D.B. Annu. Rev. Virol. 2024
A FACT-ETS-1 Antiviral Response Pathway Restricts Viral Replication and is Countered by Poxvirus A51R Proteins.
Rex EA, Seo D, Chappidi S, Pinkham C, Oliveira SB, Embry A, Heisler D, Liu Y, Luger K, Alto NM, da Fonseca FG, Orchard R, Hancks D, Gammon DB, bioRxiv 2023 Feb
How to Inhibit Nuclear Factor-Kappa B Signaling: Lessons from Poxviruses.
Reus JB, Rex EA, Gammon DB, Pathogens 2022 Sep 11 9
Manipulation of the Host Cytoskeleton by Viruses: Insights and Mechanisms.
Seo D, Gammon DB, Viruses 2022 Jul 14 7

Honors & Awards

  • Alberta Innovates Health Solutions Fellowship
  • Canadian Association for Graduate Studies Distinguished Dissertation Award
  • Govenor General's Academic Gold Medal
  • Izaak Walton Killam Scholar
  • Natural Sciences and Engineering Research Council of Canada Fellowship
  • Ralph Steinhauer Award of Distinction

Professional Associations/Affiliations

  • American Society for Virology (2005)
  • Guest Editor, IJMS (2023)
  • Guest Editor, Viruses (2020)